ABT vs GILD

Abbott Laboratories against Gilead Sciences — live side-by-side technical comparison.

Prices as of 2026-10-16T20:03:40+00:00 UTC · updates daily

Who leads right now

GILD leads 3 of the 5 windows we measure — over 1 month ABT is +2.5% and GILD +5.8%; over year to date ABT is -16.3% and GILD +27.2%. The ABT/GILD price ratio stands at 0.6716, below its 50-day average of 0.7224, and below the 200-day average of 0.7471. A ratio above its own average means ABT is gaining on GILD; on this reading the recent edge belongs to GILD.

Performance side by side

ABTGILD
Price$104.89 $156.19
1 day +0.2%lead -0.8%
5 days +5.3%lead +3.3%
1 month +2.5% +5.8%lead
6 months +9.9% +12.7%lead
Year to date -16.3% +27.2%lead
52-week position 46% of range 91% of range
52-week range $81.97–$132.03 $114.02–$160.51
vs 50-day average below $105.87 above $146.84
vs 200-day average above $102.81 above $138.03
RSI (14) 62 57
Next earnings 2026-10-212026-10-29

Where each one stands

ABT — Abbott Laboratories

ABT trades at $104.89, below its 50-day average of $105.87, and above the 200-day at $102.81. It sits at 46% of its 52-week range ($81.97–$132.03); 14-day RSI is 62, in neutral territory; an average session moves it about 2.3%. For levels, the first level overhead is $105.87 (0.9% away) and the first support below is $104.55 (0.3% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.

GILD — Gilead Sciences

GILD trades at $156.19, above its 50-day average of $146.84, and above the 200-day at $138.03. It sits at 91% of its 52-week range ($114.02–$160.51); 14-day RSI is 57, in neutral territory; an average session moves it about 2.4%. For levels, the first level overhead is $157.37 (0.8% away) and the first support below is $153.38 (1.8% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.

Which one moves harder

Both move about the same amount day to day (2.3% and 2.4% of price), so the same position size carries comparable risk in either.

What would change the picture

The comparison turns on those levels: ABT clearing $105.87 or losing $104.55; GILD clearing $157.37 or losing $153.38. Until one of them gives way, the relative reading above stands.

Questions people ask about ABT vs GILD

Which is performing better right now, ABT or GILD?
Over the past month ABT is +2.5% and GILD is +5.8%, so GILD is ahead on that window. Year to date the figures are -16.3% for ABT and +27.2% for GILD.
Is ABT or GILD more volatile?
Both move about the same amount day to day (2.3% and 2.4% of price), so the same position size carries comparable risk in either.
What are the key levels for ABT and GILD?
ABT: resistance $105.87, support $104.55; GILD: resistance $157.37, support $153.38. Levels come from recent swing zones and round numbers, recomputed daily.
When do ABT and GILD report next?
ABT: 2026-10-21. GILD: 2026-10-29. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the ABT/GILD ratio mean?
It is simply ABT's price divided by GILD's — 0.6716 today. When the ratio rises, ABT is outperforming; when it falls, GILD is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical briefs

ABT →
Abbott Laboratories
Full technical brief: trend, levels, chart, news
GILD →
Gilead Sciences
Full technical brief: trend, levels, chart, news

Related comparisons

JNJ vs LLYABBV vs LLYLLY vs UNHLLY vs MRKLLY vs TMOAMGN vs LLYGILD vs LLYABT vs LLY